Skip to content

Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries

Comparison of the Efficacy of Bilevel Erector Spinae Plane Block and Single Level Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05429489
Enrollment
126
Registered
2022-06-23
Start date
2022-06-27
Completion date
2024-01-10
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

This study aims at comparing the analgesic efficacy and safety of bilevel erector spinae versus single level versus general anesthesia for breast cancer surgeries

Interventions

Bilevel erector spinae plane block at 3rd and 5th thoracic vertebral levels

Single level erector spinae plane block at 5th thoracic vertebrae

Intravenous morphine 0.1 mg/kg

Sponsors

National Cancer Institute, Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Female * Diagnosed with breast cancer

Exclusion criteria

* Patient refusal * coagulation defects * bone metastases * abnormal kidney and/or liver function tests

Design outcomes

Primary

MeasureTime frameDescription
Total analgesic requisiteFirst 24 hours postoperativelytotal postoperative morphine consumption

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026